CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
New insulin glargine 300 U/mL: glycaemic control and hypoclycaemia in insulin-naïve people with type 2 diabetes mellitus (EDITION 3)
DOI 10.1055/s-0035-1549678
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Ziemen, MC Riddle, RM Bergenstal, K Sestakauskas, H Goyeau, PD Home, GB Bolli
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: EDITION 3 studied the efficacy and safety of new insulin glargine 300 U/mL (U300) vs. glargine 100 U/mL (Gla-100) in people with type 2 diabetes mellitus uncontrolled on non-insulin therapy. Materials and Methods: 6-month, multicenter, open-label study; participants randomized to once-daily Gla-300 or Gla-100 in the evening while stopping sulfonylureas. Insulin was titrated seeking fasting SMPG…
Zitieren
Zitierempfehlung
M Ziemen, MC Riddle, RM Bergenstal, K Sestakauskas, H Goyeau, PD Home, GB Bolli (2015) New insulin glargine 300 U/mL: glycaemic control and hypoclycaemia in insulin-naïve people with type 2 diabetes mellitus (EDITION 3). Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549678
Mit CareLit weiterarbeiten